Trump administration proposes splitting MMR vaccine into three separate shots

The Trump administration’s Department of Health and Human Services has issued a recommendation to administer the measles, mumps and rubella (MMR) vaccine as three separate injections, each given at a different clinical visit, rather than the standard combined formulation. The guidance, released in a policy brief last week, cites concerns about potential adverse reactions and suggests that spacing the components may improve monitoring of side effects and increase parental confidence in the immunization process.

Public health officials noted that the combined MMR vaccine has been endorsed by the Centers for Disease Control and Prevention and the American Academy of Pediatrics for decades, with a two‑dose schedule proven to be safe and highly effective. The new recommendation diverges from these established guidelines and could require additional clinic appointments, potentially affecting vaccination coverage rates. Health agencies are reviewing the proposal to assess its impact on disease prevention efforts and to determine whether any adjustments to the national immunization schedule will be implemented.